9587116

Source:http://linkedlifedata.com/resource/pubmed/id/9587116

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007082, umls-concept:C0007634, umls-concept:C0010803, umls-concept:C0205195, umls-concept:C0220825, umls-concept:C0289863, umls-concept:C0530993, umls-concept:C0684249, umls-concept:C1524063, umls-concept:C1546922, umls-concept:C2745888
pubmed:issue	10
pubmed:dateCreated	1998-5-27
pubmed:abstractText	Recently developed tissue polypeptide specific antigen (TPS) and CYFRA 21-1 assays determine the soluble cytokeratin 18 and 19 fragments, respectively, in serum. The authors compared the value of TPS, CYFRA 21-1, and carcinoembryonic antigen (CEA) for the diagnosis, staging, prognosis, and monitoring of patients with nonsmall cell lung carcinoma (NSCLC).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Carcinoembryonic Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Keratin-19, http://linkedlifedata.com/resource/pubmed/chemical/Keratins, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/antigen CYFRA21.1, http://linkedlifedata.com/resource/pubmed/chemical/tissue polypeptide specific antigen
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0008-543X
pubmed:author	pubmed-author:BaramTT, pubmed-author:BaratNN, pubmed-author:HechingNN, pubmed-author:LafairJJ, pubmed-author:LyassOO, pubmed-author:NismanBB, pubmed-author:PeretzTT
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	82
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1850-9
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:9587116-Adult, pubmed-meshheading:9587116-Aged, pubmed-meshheading:9587116-Aged, 80 and over, pubmed-meshheading:9587116-Antigens, Neoplasm, pubmed-meshheading:9587116-Carcinoembryonic Antigen, pubmed-meshheading:9587116-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:9587116-Evaluation Studies as Topic, pubmed-meshheading:9587116-Female, pubmed-meshheading:9587116-Humans, pubmed-meshheading:9587116-Keratin-19, pubmed-meshheading:9587116-Keratins, pubmed-meshheading:9587116-Lung Neoplasms, pubmed-meshheading:9587116-Male, pubmed-meshheading:9587116-Middle Aged, pubmed-meshheading:9587116-Monitoring, Physiologic, pubmed-meshheading:9587116-Neoplasm Staging, pubmed-meshheading:9587116-Peptides, pubmed-meshheading:9587116-Predictive Value of Tests, pubmed-meshheading:9587116-Prognosis, pubmed-meshheading:9587116-Prospective Studies, pubmed-meshheading:9587116-Tumor Markers, Biological
pubmed:year	1998
pubmed:articleTitle	Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?
pubmed:affiliation	Oncology Department, Hadassah University Hospital, Jerusalem, Israel.
pubmed:publicationType	Journal Article, Clinical Trial, Controlled Clinical Trial